| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.29 | 2e-05 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.29 | 0.0001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.24 | 0.0005 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |